BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

What's New in Myasthenia Gravis

Activity Snapshot

Activity Type: 
Release Date: 
Friday, May 14, 2021
Sponsor Information: 

This program is supported in part by an independent educational grant from Momenta and argenx


Michael Hehir, MD
Associate Professor of Neurological Sciences
University of Vermont College of Medicine
Activity Overview: 

This speaker slide set will provide an overview of myasthenia gravis (MG), including recognizing clinical symptoms, clinical management of the disease and the role of multidisciplinary care to optimize treatment outcomes.

Learning Objectives: 
  • Recognize clinical symptoms indicative of myasthenia gravis (MG)
  • Understand the optimal workflow for diagnosis based upon clinical evaluation, detection of characteristic symptoms and physical findings, a detailed patient history, and a variety of specialized tests
  • Determine a disease management plan based on knowledge of currently available therapies as well as best practice guidelines 
  • Understand the role of multidisciplinary care in optimizing treatment outcomes, including symptomatic and supportive care 
  • Incorporate recent advances in clinical studies into patient care and provide guidance to patients on the benefits of and opportunities for participation in MG research